Pharmacogenomics Market Size Worth USD 6670.3 Million by 2030 at 8.52% CAGR – Report by Market Research Future (MRFR)


Pharmacogenomics Market Trends and Insights By Technology (Microarray, Sequencing, and Polymerase Chain Reaction), By Application (Oncology, Cardiology, and Neurological Disorders), By End User (Hospitals, Research Organizations and Academic Institutes), and By Region (North America, Europe, Asia-Pacific, and the Rest of the World), Competitive Market Growth, Size, Share and Forecast to 2030

New York, USA, June 09, 2023 (GLOBE NEWSWIRE) — Pharmacogenomics Market Overview

According to a Comprehensive Research Report by Market Research Future (MRFR), “Pharmacogenomics Market Information by Technology, Application, End User, and Region – Forecast till 2030”, the market is projected to register a CAGR of 8.52% from 2022 to 2030 to reach USD 6,670.3 Million by 2030


Market Scope

The market for pharmacogenomics is being propelled by the growing acceptance of precision medicine and increased research and development spending on pharmacogenomics technologies, which hastened the creation of novel medicines. Pharmacogenomics is a field that involves studying how genes impact a person’s response to medication. It is an advanced branch of personalized medicine that enables physicians to prescribe drugs that are more effective for specific patients based on their genetic makeup. The field of pharmacogenomics has emerged as a valuable tool for reducing adverse drug reactions and optimizing treatment outcomes.

Pharmacogenomics has a wide range of applications in the field of medicine. By analyzing a patient’s genetic makeup, doctors can determine how they will respond to specific drugs, which can help in the development of personalized treatment plans. Pharmacogenomics is particularly useful in the treatment of cancer, where it is essential to identify the most effective chemotherapy drugs for each patient. It can also be used to predict the likelihood of adverse drug reactions, helping to prevent adverse events and improve patient safety.

Get Free Sample PDF Brochure @

Report Scope:

Report Attribute Details
Market Size in 2030 USD 6670.3 Million
CAGR 8.52%
Base Year 2021
Forecast Period 2022-2030
Historical Data 2020
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered by Technology, Application and End User
Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers Growing acceptance of precision medicine
Increased research and development spending on pharmacogenomics technologies

Pharmacogenomics Market Competitive Landscape:

The affluent companies in the Pharmacogenomics industry include

  • Myriad Genetics, Inc.
  • 23andMe, Inc.
  • Pathway Genomics
  • Genentech
  • Future Science Group
  • Teva Pharmaceutical Industries Ltd.
  • Assurex Health, Inc.
  • Bristol-Myers Squibb Company
  • Hoffmann-La Roche Ltd
  • Merck & Co., Inc
  • Johnson & Johnson
  • Abbott Laboratories, Inc.

August 2021

Thermo Fisher Scientific, a leading provider of scientific research products and services, announced the launch of its new pharmacogenomics assay, which enables the simultaneous detection of multiple genetic variants that impact drug metabolism. This new assay will help to improve the accuracy and speed of pharmacogenomic testing, enabling clinicians to make more informed decisions about drug selection and dosing.

Pharmacogenomics Market Trends:

Market Drivers

The pharmacogenomics market is driven by several factors, including the increasing prevalence of chronic diseases, rising demand for personalized medicine, and advancements in genomic technologies. The growing availability of affordable sequencing technologies and the increasing adoption of electronic health records are also contributing to the growth of the pharmacogenomics market. Additionally, the availability of pharmacogenomic tests for specific drugs and disease indications is expected to drive market growth in the coming years.

Market Restraints:

Despite the many benefits of pharmacogenomics, there are several market restraints to consider. The high cost of testing and the lack of reimbursement policies for pharmacogenomic testing are two significant factors that may limit the market growth. Additionally, there is a need for greater awareness and education among healthcare providers regarding the benefits of pharmacogenomics, which may impact adoption rates.

COVID 19 Analysis

The COVID-19 pandemic has had a significant impact on the pharmacogenomics market. The pandemic has highlighted the importance of personalized medicine and the need for rapid diagnostic testing. The pandemic has also accelerated the adoption of telemedicine, which has made it easier for patients to access pharmacogenomic testing services remotely. The post-COVID-19 scenario is expected to see an increased focus on personalized medicine and the adoption of pharmacogenomics in clinical practice.

Browse In-depth Market Research Report (90 Pages) on Pharmacogenomics:

Pharmacogenomics Market Segmentation

By Technology

The technologies in the market include Microarray, Sequencing, and Polymerase Chain Reaction

By Application

By Application, the segment includes Oncology, Cardiology, and Neurological Disorders

By End User

By End User, the segment includes Hospitals, Research Organizations, and Academic Institutes.

Pharmacogenomics Market Regional Insights

North America has a dominant market share in pharmacogenomics due to the increasing adoption of personalized medicine and the presence of leading pharmaceutical companies in the region. Personalized medicine involves the customization of medical treatment based on an individual’s genetics, and pharmacogenomics plays a crucial role in enabling this approach. Moreover, the presence of prominent pharmaceutical companies in the region also contributes to the growth of the pharmacogenomics market. Further, Europe is also a significant market for pharmacogenomics, primarily driven by advancements in genomics research and increasing healthcare expenditure. Genomics research is instrumental in understanding the genetic basis of diseases and developing personalized treatment approaches. As a result, the increasing focus on genomics research in Europe is expected to drive the growth of the pharmacogenomics market. Additionally, the increasing healthcare expenditure in the region is likely to support the adoption of pharmacogenomics in healthcare.

Buy Now:

Additionally, the Asia-Pacific region is expected to witness significant growth in the pharmacogenomics market due to increasing awareness of pharmacogenomics and rising demand for personalized medicine in countries such as China and India. The growing prevalence of chronic diseases and increasing investments in healthcare infrastructure in these countries are expected to drive the demand for personalized medicine and thereby, fuel the growth of the pharmacogenomics market. Furthermore, the rising focus of pharmaceutical companies in the region is also expected to contribute to the growth of the market.

Discover more research Reports on Healthcare Industry by Market Research Future:

Precision Medicine Market Research Report Information By Ecosystem Players (Pharmaceuticals and Biotechnology Companies, Diagnostic Companies, Healthcare IT Specialists/Big Data Companies, and Clinical Laboratories), By Sub-Markets (Biomarker-Based Test, Companion Diagnostics, Targeted Therapeutics, Pharmacogenomics (PGX), and Molecular Diagnostics), By Therapeutics (Cancer/Oncology, Cardiovascular Disease (CVD), Central Nervous System, and Infectious Diseases), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

Oncology Information Systems Market Research Report Information By Product & Service Type (Software and Professional Services), By Application (Medical Oncology, Radiation Oncology and Surgical Oncology), By End User (Hospitals & Oncology Clinics, Government Institutes and Research Centers), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

Microarray Analysis Market: By Product& Services (Consumables, Software and Services, Others), By Type (DNA Microarrays, Protein Microarrays), By Application (Drug discovery, Disease Diagnostic, Research Applications), By End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

CONTACT: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: [email protected] Website: 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.